• SENSEX 73,852.90
    -876.37 (--1.17%)
  • BANKNIFTY 55,488.10
    -355.90 (--0.64%)
Back

Corporate News

Marksans Pharma to review financial results at a board meeting November 4, 2026
19-Oct-2026, 04:19

Marksans Pharma Ltd. will hold a board meeting on Wednesday, November 04, 2026, to consider and approve the unaudited financial results for both standalone and consolidated entities for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for the company’s designated persons, including directors, will be closed from October 01, 2026, and will remain closed until November 06, 2026.